Stephen T. Worland - 15 May 2024 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Issuer symbol
EFTR on OTC
Transactions as of
15 May 2024
Net transactions value
+$3,039
Form type
4
Filing time
17 May 2024, 16:00:15 UTC
Previous filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $3,039 +1,806 +17% $1.68 12,494 15 May 2024 Direct F1
holding EFTR Common Stock 22,493 15 May 2024 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.